Published in Women's Health Weekly, December 15th, 2005
"We recently reported a novel phosphatidylethanolamine-binding protein, hPEBP4, as an antiapoptotic molecule. The finding led us to explore a promising approach for breast cancer therapy via silencing the expression of hPEBP4," wrote X.J. Wang and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly